Pseudoaneurysm of the Greater Palatine Artery Following Autogenous Connective Tissue Gingival Graft : A Case Series
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03454490 |
|
Recruitment Status : Unknown
Verified March 2018 by Simon Jean, Hopital de l'Enfant-Jesus.
Recruitment status was: Not yet recruiting
First Posted : March 6, 2018
Last Update Posted : March 6, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Pseudoaneurysm | Procedure: Postoperative pseudoaneurysm of the greater palatine artery |
| Study Type : | Observational |
| Estimated Enrollment : | 10 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Retrospective |
| Official Title: | Pseudoaneurysm of the Greater Palatine Artery Following Autogenous Connective Tissue Gingival Graft : A Case Series |
| Estimated Study Start Date : | March 2018 |
| Estimated Primary Completion Date : | July 2018 |
| Estimated Study Completion Date : | July 2018 |
- Procedure: Postoperative pseudoaneurysm of the greater palatine artery
Patients had an autogenous connective tissue gingival graft.
- Postoperative oral bleeding [ Time Frame: One month following autogenous connective tissue gingival graft ]Complication following autogenous connective tissue gingival graft
- Use of local hemostatic agents [ Time Frame: Six months ]Palliative method before definitive care
- Secondary effects following angiographic intervention [ Time Frame: Six months ]Postoperative infection, bone or gum necrosis, extrusion of embolization material, loss of tooth, tooth devitalization following angiographic intervention
- Number of followups required [ Time Frame: Six months ]Secondary effects following angiographic intervention
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Population : Patients having a diagnostic of pseudoaneurysm of the greater palatine artery who had an autogenous connective tissue gingival graft
- Intervention : Patients treated with local hemostatic agents or by angiographic embolization
- Comparison : None
Exclusion Criteria:
- Missing data in patients' chart precluding complete data extraction
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03454490
| Contact: Simon Jean, DMD | 1-418-649-0252 ext 63972 | simon.jean.4@ulaval.ca | |
| Contact: Marianne Bouchard-Asselin, DMD | 1-418-649-0252 ext 63972 | marianne.bouchard-asselin.1@ulaval.ca |
| Study Director: | Melinda Paris, DMD, FRCD | Hopital de l'Enfant-Jesus, CHU de Quebec, Laval University |
| Responsible Party: | Simon Jean, Principal Investigator, Hopital de l'Enfant-Jesus |
| ClinicalTrials.gov Identifier: | NCT03454490 |
| Other Study ID Numbers: |
Postoperative pseudoaneurysm |
| First Posted: | March 6, 2018 Key Record Dates |
| Last Update Posted: | March 6, 2018 |
| Last Verified: | March 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Gingival graft Pseudoaneurysm Postoperative complication |
Gingival recession treatment Palatine mass Palatine bleeding |
|
Aneurysm, False Aneurysm Vascular Diseases Cardiovascular Diseases |

